StonvexLoading…
StonvexStonvexStonvexCore line items from TFX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-28 | Annual 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $548.26M | $1.99B | $566.95M | $442.52M |
Operating Income | $20.18M | $118.37M | $-62.44M | $91.14M |
Net Income | $-8.15M | $-905.64M | $-408.89M | $122.58M |
EPS (Diluted) | $-0.18 | $-20.25 | $-9.24 | $2.77 |
Total Assets | $6.78B | $6.95B | $7.87B | $7.38B |
Total Liabilities | $3.70B | $3.82B | $4.05B | $3.13B |
Cash & Equivalents | $309.41M | $378.56M | $354.00M | $253.70M |
Free Cash Flow OCF − CapEx | $27.87M | $1.45M | $94.39M | $16.55M |
Shares Outstanding | 44.26M | 44.72M | 44.76M | 45.12M |